Akoya BioSciences, Inc. (AKYA) Dividend History

Company News

• New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

  The article discusses the growing cancer treatment market, with a focus on companies like Oncolytics Biotech, Akoya Biosciences, Quanterix, TScan Therapeutics, and Arcellx. It highlights new data and collaborations that signal a turning point for precision-driven cancer biotechs.

  Benzinga

  Featured Companies: ACLX ONCY QTRX TCRX
• $HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AKYA, WTMA, PLYA, QTRX to Act Now

  Monteverde & Associates PC, a class action law firm, is investigating several proposed mergers, including Akoya Biosciences' merger with Quanterix, Welsbach Technology Metals Acquisition's merger with Evolution Metals LLC, and Playa Hotels & Resorts' merger with Hyatt Hotels Corporation.

  GlobeNewswire Inc.

  Featured Companies: H PLYA QTRX
• Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates

  Akoya (AKYA) delivered earnings and revenue surprises of -16.67% and 23.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research
• Why Shares of Akoya Biosciences Jumped on Tuesday

  A rash of insider buying buoyed investor confidence in the medical instrument company.

  The Motley Fool
• Akoya Biosciences shares fall 10% on executive exits, stock offering

  Shares of Akoya Biosciences on Wednesday dropped 10% to $5.00 in after-hours trading after the company said it fired its chief medical officer and chief people officer as part of a cost-cutting plan.

  MarketWatch